ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ.

Brian L Heiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.